Asst. Omid Mohsen Hassan

PERSONAL INFORMATION

Name: OMEED MUHSIN HASSAN

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

EDUCATION

- B.Sc. in Pharmacy - University of Baghdad – College of Pharmacy 2000.

- M.Sc. in Pharmaceutical Chemistry- University of Baghdad – College of Pharmacy 2018.

- PhD. in Pharmaceutical Chemistry- University of Baghdad – College of Pharmacy 2023.

POSITIONS & EXPERIENCES

- Certified Clinical Pharmacist- Ibn al-Balady Hospital- Baghdad 2001.

- Head of Clinical Pharmacy unit in Azadi General Hospital- Kirkuk 2002.

- Head of Pharmacy unit in Azadi General Hospital- Kirkuk 2004.

- Head of Pharmacy unit in Kirkuk Health District till 2009.

- Certificate in HPLC from WATERS Company USA – Malaysia 2010.

- Paper and Poster presentation in Wound Healing extract Aerosol – Jakarta – 2010.

- Certificate for chemical safety at laboratories for pharmacy students. USM /

MALAYSIA.

- Chairman of the Disciplinary Committee for the Northern Region of the Iraqi

Pharmacists Syndicate 2018-2021.

- Representative of the Iraqi Pharmacists Syndicate in Kirkuk Governorate 2021-2024

- Lecturer Doctor at University of Kirkuk – College of Pharmacy - till now.

- Participated as contributor in Iraqi Drug Guide version 1 – 2023.

- Member in Scientific Committee at Syndicate of Iraqi Pharmacist / General Head Quarter. 2024 - till now.

- Head of Pharmaceutical Chemistry Department. University of Kirkuk- college of pharmacy – Till now.

- Scopus ID: 57209507755 / 0009-0000-3182-5775 - Author’s ORCID profile.

- Certified from SCHRODINGER and college of pharmacy / University of Baghdad in

rational computational drug design approaches.

• International Diploma certificate in operationa in pharmaceutical industries from liverpool college for international studies
• Lecturer and speaker for more than five pharmacerutical companies in different occasions

RESEARCHES

• Synthesis, characterization and preliminary anti-inflammatory evaluation of new etodolac derivatives – 2019.
• Design, Synthesis, and Molecular Docking Studies of 5-Bromoindole-2-Carboxylic Acid Hydrazone Derivatives: In Vitro Anticancer and VEGFR-2 Inhibitory Effects.- 2022.
• Novel 5-bromoindole-2-carboxylic Acid Derivatives as EGFR Inhibitors: Synthesis, Docking Study, and Structure Activity Relationship. – 2023.
• Antiangiogenic activity of 5-bromoindole carbothioamide derivative in ex vivo, in vivo, and in vitro experimental study -2024.
• Anti-AngiogenicandAnti-ProliferativeActivityof4-2-(5-bromo-1H-indol-2-carbonyl)-N-(4-methoxyphenyl) Hydrazine-1carbothioamide: Ex-vivo and in vitro Study. -2024.
• The mitigating effect of a topical preparation of amlodipine on imiquimod-induced psoriasis-like lesion in mice. - 2024.
• Inhibitory effects of carbohydrazide indole derivative on micro-blood vessel growth using ex vivo, in vivo, and in vitro assays. – 2025.
• Anti-Angiogenic and Anti-Proliferative Activities of 5-Bromo-N-(2,5-Dioxopyrrolidin-1-Yl)-1H-Indole-2-Carboxamide.- 2025.
• Anti-angiogenic and anti-oxidant effects of 2-NTI indole derivative vs. suramin in ex vivo, in vivo, and in vitro studies.- 2025.
• Fatty Acid Composition of Haruan (Channa striatus) Aqueous Extract for Wound Healing. – 2011.
• Haruan Spray for Burn and Wound. – 2010.
• Validation Method on Amino Acid Determination Using 6-Aminoquinolyl-N-Hydroxysuccinimidyl Carbamate (AQC) for Haruan (Channa striatus) Aqueous Extract. – 2010.
• Wound Healing Effect of Haruan Spray: A Tensile Strength Study. -2009.
• Biological Reactivity Test of Haruan (Channa striatus) Spray as Wound Dressing.- 2009.